|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Rating Action: Moody's assigns B2 CFR to PharMerica Corporation; outlook stable. Global Credit Research- 12 Sep 2017. New York, September 12, 2017-- Moody's Investors Service today assigned a B2 Corporate ...
Rating Action: Moody's Upgrades Four, Affirms Eleven and Downgrades One Classes of WBCMT 2007- C34. Global Credit Research- 31 Aug 2017. Approximately $437.7 Million of Structured Securities Affected.
Rating Action: Moody's Affirms One and Downgrades One Class of WBCMT 2006- C23. Global Credit Research- 24 Aug 2017. Approximately $43 Million of Structured Securities Affected.